ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sphere of biopharmaceuticals, giving promising progress throughout numerous professional medical and industrial programs. With its structural similarity to Obviously derived human serum albumin, OsrHSA offers a safer, additional reputable choice for therapeutic